Please login to the form below

Not currently logged in
Email:
Password:

Roche reduces greenhouse gas emissions ahead of schedule

Roche achieves a 10.8 per cent reduction in greenhouse gas emissions since at its US sites

Swiss-headquartered pharmaceutical company Roche has achieved a 10.8 per cent reduction in greenhouse gas (GHG) emissions since 2001 at its US sites.

The reduction is two years ahead of the goal set by Roche in support of the US Environmental Protection Administration's (EPA) Climate Leaders programme, which was launched back in 2002.

The EPA's Climate Leaders programme is a voluntary industry-government partnership to develop long-term comprehensive climate change strategies. Industry Partners set corporate-wide greenhouse gas (GHG) reduction goals and inventory their emissions regularly to measure progress.

Roche's goal was a combined 10 per cent reduction of 2001 greenhouse gas emissions by the end of 2008.

Roche has also submitted new goals scheduled to be achieved by 2010. In the next three years, Roche has pledged to further reduce greenhouse gas emissions across the country and will move from a 10 per cent goal to a 15 per cent reduction of gases by 2010.

In September 2007, Roche was awarded the first Financial Times / Citi Private Bank Environmental Award as the company with "The Greatest Improvement in Carbon Efficiency Achieved by a Large Enterprise both on a European and a Global Level."

5th December 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Infographics